Reckitt Benckiser Group plc Sponsored ADR logo

Reckitt Benckiser Group plc Sponsored ADR (RBGLY)

Market Closed
3 Jun, 20:00
OTC PINK OTC PINK
$
12. 13
-0.01
-0.08%
$
39.31B Market Cap
18.91 P/E Ratio
255.6% Div Yield
51,968 Volume
0 Eps
$ 12.14
Previous Close
Add Transaction
Day Range
12.09 12.18
Year Range
12.02 17.8
Want to track RBGLY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Reckitt Benckiser up 10% after being cleared of liability in preterm formula case

Reckitt Benckiser up 10% after being cleared of liability in preterm formula case

Shares in British consumer goods company Reckitt Benckiser jumped over 10% on Friday after the company, along with U.S.-based Abbott Labs, was cleared of liability in a preterm formula case.

Reuters | 1 year ago
RBGLY or CLX: Which Is the Better Value Stock Right Now?

RBGLY or CLX: Which Is the Better Value Stock Right Now?

Investors interested in Soap and Cleaning Materials stocks are likely familiar with Reckitt Benckiser Group PLC (RBGLY) and Clorox (CLX). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 1 year ago
Reckitt Benckiser results 'good enough' but not out of the woods yet

Reckitt Benckiser results 'good enough' but not out of the woods yet

Shares in Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) rose almost 4% to a six-month high after the Cilit Bang, Nurofen and Durex maker reported a smaller fall in sales than investors feared. Third-quarter numbers showed group organic sales down 0.5%, beating the average City analyst forecast for a 1.7% decline.

Proactiveinvestors | 1 year ago
Reckitt Benckiser posts drop in revenue as nutrition wing weighs

Reckitt Benckiser posts drop in revenue as nutrition wing weighs

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) has said sales fell over the third quarter as revenue from its nutrition wing slumped. Like for like revenue declined by 0.5% to £3,46 billion during the quarter, the consumer goods firm said, or by 4.0% on an international reporting standards basis.

Proactiveinvestors | 1 year ago
Healthcare helps Reckitt beat quarterly sales estimates

Healthcare helps Reckitt beat quarterly sales estimates

Reckitt reported a smaller than expected fall in third-quarter underlying sales on Wednesday, helped by its health business, which makes Nurofen painkillers and Strepsils lozenges.

Reuters | 1 year ago
Reckitt promotional push threatens sales as earnings loom

Reckitt promotional push threatens sales as earnings loom

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) will offer up third-quarter results next Wednesday, 23 October reflecting what analysts believe will have seen a drop in sales. Barclays analysts forecast organic sales growth to have fallen by 1.2% over the quarter as weaker prices offset volume growth.

Proactiveinvestors | 1 year ago
RBGLY vs. CLX: Which Stock Is the Better Value Option?

RBGLY vs. CLX: Which Stock Is the Better Value Option?

Investors looking for stocks in the Soap and Cleaning Materials sector might want to consider either Reckitt Benckiser Group PLC (RBGLY) or Clorox (CLX). But which of these two stocks is more attractive to value investors?

Zacks | 1 year ago
Reckitt Benckiser could return £12.5bn after overhaul, says leading investment bank

Reckitt Benckiser could return £12.5bn after overhaul, says leading investment bank

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) could return up to £12.5 billion to shareholders, about 40% of its market value, as part of a major strategic overhaul, according to Barclays. The company plans to shift from a category-first model to a geography-first approach, with asset sales playing a key role.

Proactiveinvestors | 1 year ago
Reckitt Benckiser has sales and legal risks aplenty as third-quarter results approach

Reckitt Benckiser has sales and legal risks aplenty as third-quarter results approach

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) is facing multiple challenges ahead of its third-quarter results, with Jefferies forecasting a -1% drop in like-for-like sales. Key reasons for the limp forecast include weaker scanner data from the US and the impact of a tornado on the company's nutrition segment, which is expected to be heavily weighted in the third quarter.

Proactiveinvestors | 1 year ago
Reckitt in talks to sell £6bn homecare portfolio, reports Bloomberg

Reckitt in talks to sell £6bn homecare portfolio, reports Bloomberg

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) is in talks with interested parties to dispose of its £6 billion homecare portfolio, which includes household brands Air Wick, Mortein, Calgon and Cillit Bang, Bloomberg has reported. The reported discussions align with an announcement from the FTSE 100-listed FMCG giant in July that plans to get rid of certain non-core products from its portfolio.

Proactiveinvestors | 1 year ago
Reckitt initiates discussions on $7.9 billion homecare assets sale, Bloomberg reports

Reckitt initiates discussions on $7.9 billion homecare assets sale, Bloomberg reports

Reckitt Benckiser has initiated early discussions with potential suitors for a sale of its homecare assets, which could be worth over 6 billion pounds ($7.89 billion), Bloomberg News reported on Tuesday.

Reuters | 1 year ago
Reckitt restructuring will see 30% of business divested - analyst

Reckitt restructuring will see 30% of business divested - analyst

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB)'s dramatic upheaval plans will result in the divestment of approximately 30% of its business, according to analysis from UBC. Announced alongside an interim trading update on Wednesday, the restructuring forms part of Reckitt's strategy to sharpen its brand portfolio and streamline its operations, focusing on higher-growth, high-margin Powerbrands.

Proactiveinvestors | 1 year ago
Loading...
Load More